Results 161 to 170 of about 24,901 (225)

Lack of Sex Differences in Psychostimulant-Induced Locomotor Activity When Comparing Rats From the Same Behavioral Groups. [PDF]

Biol Psychiatry Glob Open Sci
Tigano AM, Job MO.
europepmc   +1 more source

Practical tools for female-specific ADHD: The impact of hormonal fluctuations in clinical practice and from the literature. [PDF]

Eur Psychiatry
Wynchank D, de Jong M, Kooij SJJS.
europepmc   +1 more source

Treatment with rapamycin prevents induction and expression of locomotor sensitization to synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV) in mice. [PDF]

Forensic Toxicol
Wojcieszak J, Kuczyńska K, Zawilska JB.
europepmc   +1 more source

Raynaud's phenomenon during treatment with lisdexamfetamine: risk of cerebral vasospasm? [PDF]

Einstein (Sao Paulo)
Pitliuk R, Fucci TPPDCS.
europepmc   +1 more source

Strategic approaches to reducing the substance use-related burden of disease in Canada. [PDF]

Lancet Reg Health Am
Fischer B, Hall W, Le Foll B, Conrod P.
europepmc   +1 more source

Attention-deficit hyperactivity disorder medication discontinuation during pregnancy and resumption postpartum. [PDF]

Am J Obstet Gynecol MFM
Xu KY, Pappas LM, Brown TR, Jansen MO, Tardelli VS, Fidalgo TM, Levin FR, Grucza RA, Suarez EA, Smid MC, Horns JJ, Bruno AM.   +11 more
europepmc   +1 more source

Adverse events and safety concerns among university students who misused stimulants to increase academic performance. [PDF]

Einstein (Sao Paulo)
Moreira JE, Rodrigues MCL, Palhares CVT, Oliveira THC, Gonçalves GKN.   +4 more
europepmc   +1 more source

Disposition and effects of alpha-pyrrolidinoisohexanophenone (α-PHiP) in comparison with cocaine: an observational study. [PDF]

Front Pharmacol
De la Rosa G, Iacobone G, Papaseit E, Hladun O, Poyatos L, Caicedo DA, Argote MC, Martín S, Ventura M, Di Giorgi A, Graziano S, Pichini S, Marchei E, Farré M, Pérez-Mañá C.   +14 more
europepmc   +1 more source

The impact of psychostimulant use on office based buprenorphine treatment retention. [PDF]

Harm Reduct J
Edgerton R, Rebeiro P, MacMaster S, Bell L, Patel P, Ginn L, Beach K, Shah V, Cooper RL.   +8 more
europepmc   +1 more source

Heart Rate Variability Prediction of Stimulant-Induced Creativity Gains in Attention-Deficit/Hyperactivity Disorder. [PDF]

J Clin Med
Appling C, Nuraini N, Hart E, Wang D, Tosh A, Beversdorf D, Ferguson B.   +6 more
europepmc   +1 more source